ArticleJournal of hepatocellular carcinoma2023

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study.

Xu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.